Medications for Hepatic Encephalopathy
5 results
Generlac (lactulose)
(Lactulose)Chartwell RX, LLC
Usage: Lactulose solution is indicated for the prevention and treatment of portal-systemic encephalopathy, including hepatic pre-coma and coma. It effectively reduces blood ammonia levels, improving mental state and EEG patterns, with a satisfactory clinical response in approximately 75% of patients. Additionally, it often enhances protein tolerance.
Humatin (paromomycin sulfate)
(PAROMOMYCIN SULFATE)Waylis Therapeutics LLC
Usage: Paromomycin sulfate is indicated for treating acute and chronic intestinal amebiasis and as adjunctive therapy in managing hepatic coma. It should be used to treat or prevent infections caused by susceptible bacteria to avoid drug resistance.
Lactulose (lactulose)
(Lactulose)APOZEAL PHARMACEUTICALS INC
Usage: Lactulose is indicated for preventing and treating portal-systemic encephalopathy, including hepatic pre-coma and coma. It effectively reduces blood ammonia levels and improves mental state in about 75% of patients, enhancing protein tolerance, and has shown efficacy in long-term use.
Neomycin sulfate (neomycin sulfate)
(Neomycin Sulfate)XGen Pharmaceuticals DJB, Inc.
Usage: Neomycin Sulfate Tablets are indicated to prevent drug-resistant bacteria by treating infections caused by susceptible bacteria, suppressing intestinal flora for bowel preparation, and as adjunctive therapy in hepatic coma to reduce ammonia-forming bacteria, improving neurologic symptoms.
Xifaxan (rifaximin)
(rifaximin)Salix Pharmaceuticals Inc
Usage: XIFAXAN is indicated for the treatment of travelers’ diarrhea caused by noninvasive strains of E. coli in patients 12 years and older, reduction of overt hepatic encephalopathy recurrence in adults, and treatment of irritable bowel syndrome with diarrhea in adults. It should only be used for confirmed or likely infections.